000301491 001__ 301491
000301491 005__ 20250901154116.0
000301491 0247_ $$2doi$$a10.1093/pubmed/fdaf055
000301491 0247_ $$2pmid$$apmid:40377264
000301491 0247_ $$2ISSN$$a1741-3842
000301491 0247_ $$2ISSN$$a0142-2456
000301491 0247_ $$2ISSN$$a0957-4832
000301491 0247_ $$2ISSN$$a1464-3782
000301491 0247_ $$2ISSN$$a1741-3850
000301491 0247_ $$2ISSN$$a2753-5517
000301491 037__ $$aDKFZ-2025-01033
000301491 041__ $$aEnglish
000301491 082__ $$a610
000301491 1001_ $$00000-0003-2906-3438$$aFantin, Romain$$b0
000301491 245__ $$aA population-based case-control study of COVID-19: methodological considerations on the role of testing bias.
000301491 260__ $$aOxford$$bOxford Univ. Press$$c2025
000301491 3367_ $$2DRIVER$$aarticle
000301491 3367_ $$2DataCite$$aOutput Types/Journal article
000301491 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1756734035_32343
000301491 3367_ $$2BibTeX$$aARTICLE
000301491 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000301491 3367_ $$00$$2EndNote$$aJournal Article
000301491 500__ $$aVolume 47, Issue 3, September 2025, Pages e250–e261
000301491 520__ $$aTargeting people at risk of COVID-19 infection has been critical to containing the pandemic. Using only differences in cumulative incidence by sociodemographic groups can be misleading, as it reflects both factors related to infection risk and those related to testing for infection. The aim of this analysis was to disentangle the determinants of both mechanisms.We compared the demographic, socioeconomic, and health characteristics of 813 PCR-confirmed COVID-19 cases over age 20 years with 1630 age- sex- and geography-matched population-based controls, both recruited in 2020-2021 in the RESPIRA study. We used antibody results and previous diagnosis to detect infections in population-based controls.High socioeconomic status and being older than 60 years old were negatively associated with seropositivity. Obesity and number of people living in the household were positively associated with seropositivity. Among infected (seropositive) people, diagnosis by PCR was more frequent in employees, and in people with asthma or hypertension, and was negatively associated with the number of people living in the household.Differences between PCR-confirmed cases and non-infected controls reflected differences both in risk of infection, and in PCR-testing in infected people. The possibility of PCR-testing bias in case-control studies of COVID should be considered in future research.
000301491 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000301491 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000301491 650_7 $$2Other$$aCOVID-19 serological testing
000301491 650_7 $$2Other$$aCOVID-19 testing
000301491 650_7 $$2Other$$aCosta Rica
000301491 650_7 $$2Other$$aLatin America
000301491 650_7 $$2Other$$amiddle-income country
000301491 650_7 $$2Other$$asocial determinants of health
000301491 7001_ $$00000-0002-4592-3883$$aPorras, Carolina$$b1
000301491 7001_ $$aAparicio, Amada$$b2
000301491 7001_ $$aVanegas, Juan Carlos$$b3
000301491 7001_ $$aLoria, Viviana$$b4
000301491 7001_ $$aMorera, Melvin$$b5
000301491 7001_ $$aAbdelnour, Arturo$$b6
000301491 7001_ $$0P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30$$aWaterboer, Tim$$b7$$udkfz
000301491 7001_ $$0P:(DE-He78)31d7c3e829be03400641f80b821ef728$$aButt, Julia Anna$$b8$$udkfz
000301491 7001_ $$aPfeiffer, Ruth M$$b9
000301491 7001_ $$aPrevots, D Rebecca$$b10
000301491 7001_ $$aGail, Mitchell H$$b11
000301491 7001_ $$aHildesheim, Allan$$b12
000301491 7001_ $$aHerrero, Rolando$$b13
000301491 7001_ $$aGroup, RESPIRA Study$$b14$$eCollaboration Author
000301491 7001_ $$aCalderón, Alejandro$$b15$$eContributor
000301491 7001_ $$aMoreno, Karla$$b16$$eContributor
000301491 7001_ $$aWong, Roy$$b17$$eContributor
000301491 7001_ $$aCastro, Roberto$$b18$$eContributor
000301491 7001_ $$aCortés, Bernal$$b19$$eContributor
000301491 7001_ $$aOcampo, Rebecca$$b20$$eContributor
000301491 7001_ $$aZúñiga, Michael$$b21$$eContributor
000301491 7001_ $$aSun, Kaiyuan$$b22$$eContributor
000301491 7001_ $$aBarboza-Solís, Cristina$$b23$$eContributor
000301491 7001_ $$0P:(DE-He78)2fb2bd9048a3777dddc4cb89b115c187$$aBinder, Marco$$b24$$eContributor$$udkfz
000301491 773__ $$0PERI:(DE-600)1497445-9$$a10.1093/pubmed/fdaf055$$gp. fdaf055$$n3$$pe250–e261$$tJournal of public health$$v47$$x1741-3842$$y2025
000301491 909CO $$ooai:inrepo02.dkfz.de:301491$$pVDB
000301491 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000301491 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)31d7c3e829be03400641f80b821ef728$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000301491 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2fb2bd9048a3777dddc4cb89b115c187$$aDeutsches Krebsforschungszentrum$$b24$$kDKFZ
000301491 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000301491 9141_ $$y2025
000301491 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2025-01-03$$wger
000301491 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-03
000301491 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-03
000301491 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-03
000301491 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-03
000301491 915__ $$0StatID:(DE-HGF)1180$$2StatID$$aDBCoverage$$bCurrent Contents - Social and Behavioral Sciences$$d2025-01-03
000301491 915__ $$0StatID:(DE-HGF)0130$$2StatID$$aDBCoverage$$bSocial Sciences Citation Index$$d2025-01-03
000301491 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-03
000301491 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-03
000301491 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-03
000301491 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-03
000301491 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-03
000301491 9201_ $$0I:(DE-He78)D320-20160331$$kD320$$lInfektionen und Krebs-Epidemiologie$$x0
000301491 9201_ $$0I:(DE-He78)D430-20160331$$kD430$$lVirus-assoziierte Karzinogenese$$x1
000301491 980__ $$ajournal
000301491 980__ $$aVDB
000301491 980__ $$aI:(DE-He78)D320-20160331
000301491 980__ $$aI:(DE-He78)D430-20160331
000301491 980__ $$aUNRESTRICTED